Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization
Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for coronavirus disease 2019 (COVID-19).Material and methods. The study included 185 patients from the TARGET-VIP registry who came for a visit 12 month...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2023-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3437 |
| _version_ | 1827063632979034112 |
|---|---|
| author | Yu. V. Mareev M. M. Lukyanov S. Yu. Martsevich A. A. Pulin N. P. Kutishenko E. Yu. Andreenko V. P. Voronina V. A. Dindikova N. A. Dmitrieva A. N. Makoveeva O. V. Lerman E. Yu. Okshina A. A. Smirnov M. M. Kudryavtseva E. N. Belova V. G. Klyashtorny E. V. Kudryashov O. E. Karpov O. M. Drapkina |
| author_facet | Yu. V. Mareev M. M. Lukyanov S. Yu. Martsevich A. A. Pulin N. P. Kutishenko E. Yu. Andreenko V. P. Voronina V. A. Dindikova N. A. Dmitrieva A. N. Makoveeva O. V. Lerman E. Yu. Okshina A. A. Smirnov M. M. Kudryavtseva E. N. Belova V. G. Klyashtorny E. V. Kudryashov O. E. Karpov O. M. Drapkina |
| author_sort | Yu. V. Mareev |
| collection | DOAJ |
| description | Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for coronavirus disease 2019 (COVID-19).Material and methods. The study included 185 patients from the TARGET-VIP registry who came for a visit 12 months after hospitalization for COVID-19. To identify HF with reduced (HFrEF) and mildly reduced (HFmrEF) ejection fraction (EF), the European Society of Cardiology (ESC) criteria (2016 and 2021) were used. To identify HF with preserved EF (HFpEF), we used the ESC criteria (2016 and 2021), as well as the 2018 Russian guidelines and H2FPEF score.Results. In the analyzed group, there were no patients with EF <40%, while one patient had EF of 48% and 184 patients — ≥50%. The patient with EF of 48% was not diagnosed with HF due to the absence of HF signs and symptoms. The presence of HFpEF was confirmed in 31,4% of patients according to 2018 Russian criteria and 2021 ESC criteria (first version of the diagnosis), in 12,5% according to the 2016 ESC criteria, 11% according to ESC 2021 criteria (second version of the diagnosis) and in 2,2% on the H2FPEF score. The proportion of HF diagnosed for the first time according to the 2016 ESC criteria was 78% of the total number of HF cases.Conclusion. Among the examined patients 12 months after hospital treatment for COVID-19, there were no cases of HFrEF and HFmrEF. The proportion of HFpEF cases, depending on the diagnostic criteria used, varied significantly from 2,2 to 31,4%. The previously established diagnosis of HF was confirmed in 83% of cases at a visit 12 months after discharge from the hospital. Using the 2016 ESC criteria and the corresponding 2020 Russian Society of Cardiology guidelines, the proportion of newly diagnosed HF was 78% of all patients. |
| first_indexed | 2024-04-10T03:32:53Z |
| format | Article |
| id | doaj.art-49b9b47e487a4876a7816da4c07136a4 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:34:21Z |
| publishDate | 2023-01-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-49b9b47e487a4876a7816da4c07136a42024-10-17T12:21:43Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252023-01-01211210.15829/1728-8800-2022-34372560Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalizationYu. V. Mareev0M. M. Lukyanov1S. Yu. Martsevich2A. A. Pulin3N. P. Kutishenko4E. Yu. Andreenko5V. P. Voronina6V. A. Dindikova7N. A. Dmitrieva8A. N. Makoveeva9O. V. Lerman10E. Yu. Okshina11A. A. Smirnov12M. M. Kudryavtseva13E. N. Belova14V. G. Klyashtorny15E. V. Kudryashov16O. E. Karpov17O. M. Drapkina18National Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicinePirogov National Medical and Surgical CenterNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicineNational Medical Research Center for Therapy and Preventive MedicinePirogov National Medical and Surgical CenterNational Medical Research Center for Therapy and Preventive MedicineAim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for coronavirus disease 2019 (COVID-19).Material and methods. The study included 185 patients from the TARGET-VIP registry who came for a visit 12 months after hospitalization for COVID-19. To identify HF with reduced (HFrEF) and mildly reduced (HFmrEF) ejection fraction (EF), the European Society of Cardiology (ESC) criteria (2016 and 2021) were used. To identify HF with preserved EF (HFpEF), we used the ESC criteria (2016 and 2021), as well as the 2018 Russian guidelines and H2FPEF score.Results. In the analyzed group, there were no patients with EF <40%, while one patient had EF of 48% and 184 patients — ≥50%. The patient with EF of 48% was not diagnosed with HF due to the absence of HF signs and symptoms. The presence of HFpEF was confirmed in 31,4% of patients according to 2018 Russian criteria and 2021 ESC criteria (first version of the diagnosis), in 12,5% according to the 2016 ESC criteria, 11% according to ESC 2021 criteria (second version of the diagnosis) and in 2,2% on the H2FPEF score. The proportion of HF diagnosed for the first time according to the 2016 ESC criteria was 78% of the total number of HF cases.Conclusion. Among the examined patients 12 months after hospital treatment for COVID-19, there were no cases of HFrEF and HFmrEF. The proportion of HFpEF cases, depending on the diagnostic criteria used, varied significantly from 2,2 to 31,4%. The previously established diagnosis of HF was confirmed in 83% of cases at a visit 12 months after discharge from the hospital. Using the 2016 ESC criteria and the corresponding 2020 Russian Society of Cardiology guidelines, the proportion of newly diagnosed HF was 78% of all patients.https://cardiovascular.elpub.ru/jour/article/view/3437heart failureheart failure with preserved ejection fractioncovid-19h2fpef scorebrain natriuretic propeptide |
| spellingShingle | Yu. V. Mareev M. M. Lukyanov S. Yu. Martsevich A. A. Pulin N. P. Kutishenko E. Yu. Andreenko V. P. Voronina V. A. Dindikova N. A. Dmitrieva A. N. Makoveeva O. V. Lerman E. Yu. Okshina A. A. Smirnov M. M. Kudryavtseva E. N. Belova V. G. Klyashtorny E. V. Kudryashov O. E. Karpov O. M. Drapkina Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization Кардиоваскулярная терапия и профилактика heart failure heart failure with preserved ejection fraction covid-19 h2fpef score brain natriuretic propeptide |
| title | Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
| title_full | Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
| title_fullStr | Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
| title_full_unstemmed | Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
| title_short | Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
| title_sort | detection rate and characteristics of heart failure depending on the diagnostic criteria in covid 19 survivors one year after hospitalization |
| topic | heart failure heart failure with preserved ejection fraction covid-19 h2fpef score brain natriuretic propeptide |
| url | https://cardiovascular.elpub.ru/jour/article/view/3437 |
| work_keys_str_mv | AT yuvmareev detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT mmlukyanov detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT syumartsevich detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT aapulin detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT npkutishenko detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT eyuandreenko detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT vpvoronina detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT vadindikova detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT nadmitrieva detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT anmakoveeva detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT ovlerman detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT eyuokshina detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT aasmirnov detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT mmkudryavtseva detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT enbelova detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT vgklyashtorny detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT evkudryashov detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT oekarpov detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization AT omdrapkina detectionrateandcharacteristicsofheartfailuredependingonthediagnosticcriteriaincovid19survivorsoneyearafterhospitalization |